Similar articles

• The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

  Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. Maxwell PH, et al. Nature. 1999 May 20;399(6733):271-5. doi: 10.1038/20459. Nature. 1999. PMID: 10353251
• VHL takes HIF's breath away.

  Krek W. Krek W. Nat Cell Biol. 2000 Jul;2(7):E121-3. doi: 10.1038/35017129. Nat Cell Biol. 2000. PMID: 10878820
• The von Hippel-Lindau tumor suppressor protein.

  Ivan M, Kaelin WG Jr. Ivan M, et al. Curr Opin Genet Dev. 2001 Feb;11(1):27-34. doi: 10.1016/s0959-437x(00)00152-0. Curr Opin Genet Dev. 2001. PMID: 11163147 Review.
• The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.

  Barry RE, Krek W. Barry RE, et al. Trends Mol Med. 2004 Sep;10(9):466-72. doi: 10.1016/j.molmed.2004.07.008. Trends Mol Med. 2004. PMID: 15350900 Review. No abstract available.
• The von Hippel-Lindau tumor suppressor gene.

  Kondo K, Kaelin WG Jr. Kondo K, et al. Exp Cell Res. 2001 Mar 10;264(1):117-25. doi: 10.1006/excr.2000.5139. Exp Cell Res. 2001. PMID: 11237528 Review.